Clinical Trial Update: A Long-term Follow up Study of EXG102-031 in Participants With wAMD

View source ↗

Summary

A long-term follow-up study of EXG102-031 for wet age-related macular degeneration is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wet Age-related Macular Degeneration

Drugs mentioned

• EXG102-031

Snippet

Sponsor: Guangzhou Jiayin Biotech Ltd | Conditions: Wet Age-related Macular Degeneration | Status: RECRUITING